Junhong Han

5.1k total citations · 1 hit paper
74 papers, 2.9k citations indexed

About

Junhong Han is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junhong Han has authored 74 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Junhong Han's work include Epigenetics and DNA Methylation (21 papers), Genomics and Chromatin Dynamics (20 papers) and RNA modifications and cancer (18 papers). Junhong Han is often cited by papers focused on Epigenetics and DNA Methylation (21 papers), Genomics and Chromatin Dynamics (20 papers) and RNA modifications and cancer (18 papers). Junhong Han collaborates with scholars based in China, United States and Japan. Junhong Han's co-authors include Zhiguo Zhang, Hui Zhou, Rui-Ming Xu, Shengyong Yang, Fei Mo, Yuan Cheng, Xiawei Wei, Xuelei Ma, He Cai and Manni Wang and has published in prestigious journals such as Science, Cell and Nucleic Acids Research.

In The Last Decade

Junhong Han

69 papers receiving 2.9k citations

Hit Papers

Targeting epigenetic regulators for cancer therapy: mecha... 2019 2026 2021 2023 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhong Han China 24 2.5k 463 385 182 178 74 2.9k
Michelle T. Paulsen United States 25 1.8k 0.7× 481 1.0× 410 1.1× 137 0.8× 172 1.0× 55 2.4k
Katherine M. Hannan Australia 30 2.9k 1.2× 348 0.8× 668 1.7× 160 0.9× 152 0.9× 64 3.6k
Kishor K. Bhakat United States 31 2.9k 1.2× 521 1.1× 681 1.8× 191 1.0× 272 1.5× 59 3.4k
Isabella Manni Italy 25 1.9k 0.8× 494 1.1× 785 2.0× 123 0.7× 171 1.0× 57 2.5k
Talya L. Dayton United States 17 1.1k 0.5× 622 1.3× 460 1.2× 118 0.6× 109 0.6× 28 1.9k
Hong Zeng China 30 2.1k 0.9× 467 1.0× 420 1.1× 96 0.5× 155 0.9× 120 2.9k
Wenhua Tang United States 20 1.6k 0.7× 656 1.4× 675 1.8× 91 0.5× 151 0.8× 33 2.2k
Barbara Majello Italy 32 2.7k 1.1× 408 0.9× 557 1.4× 245 1.3× 322 1.8× 77 3.3k
Qi‐En Wang United States 29 1.8k 0.7× 447 1.0× 777 2.0× 108 0.6× 180 1.0× 65 2.4k
Tsuyoshi Ikura Japan 31 3.4k 1.4× 420 0.9× 705 1.8× 156 0.9× 324 1.8× 61 3.9k

Countries citing papers authored by Junhong Han

Since Specialization
Citations

This map shows the geographic impact of Junhong Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhong Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhong Han more than expected).

Fields of papers citing papers by Junhong Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhong Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhong Han. The network helps show where Junhong Han may publish in the future.

Co-authorship network of co-authors of Junhong Han

This figure shows the co-authorship network connecting the top 25 collaborators of Junhong Han. A scholar is included among the top collaborators of Junhong Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhong Han. Junhong Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yang, Xuyang Yang, Su Zhang, et al.. (2025). MicroRNA-6084 orchestrates angiogenesis and liver metastasis in colorectal cancer via extracellular vesicles. JCI Insight. 10(14). 2 indexed citations
2.
Xu, Ying, Meng Yang, Yongfeng Xu, Junhong Han, & Qing Zhu. (2025). Epigenetic mechanisms in non-small cell lung cancer therapy and chemoresistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(4). 189356–189356.
3.
Yang, Xiaojuan, Jiang Zhu, Tao Xue, et al.. (2025). Challenges and opportunities for the diverse substrates of SPOP E3 ubiquitin ligase in cancer. Theranostics. 15(13). 6111–6145. 1 indexed citations
4.
Huang, Qing, Juan Zhao, Yang Zhang, et al.. (2025). eIF3i facilitates NELFCD translation to promote metastasis via regulating EMT and invadopodia. British Journal of Cancer. 134(7). 996–1005.
5.
Liu, Sicheng, Yang Zhang, Yang Meng, et al.. (2025). Multi-omics analyses identify mannose phosphate isomerase-centered hypoxia-induced angiogenesis signature in colorectal cancer. Journal of Translational Medicine. 23(1). 1246–1246.
6.
Liu, Sicheng, Yang Meng, Yaguang Zhang, et al.. (2024). Integrative analysis of senescence-related genes identifies robust prognostic clusters with distinct features in hepatocellular carcinoma. Journal of Advanced Research. 69. 107–123. 11 indexed citations
7.
Li, Yanbo, Sicheng Liu, Lei Xue, et al.. (2024). Profiling immune cell-related gene features and immunoregulatory ceRNA in ischemic stroke. Molecular Biomedicine. 5(1). 72–72. 2 indexed citations
8.
Zhang, Yang, Xuyang Yang, Su Zhang, et al.. (2023). Reactive oxygen species in colorectal cancer adjuvant therapies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166922–166922. 9 indexed citations
9.
Xu, Yongfeng, et al.. (2023). The dual role of p63 in cancer. Frontiers in Oncology. 13. 1116061–1116061. 9 indexed citations
10.
Qiu, Lei, Jing Qian, Yanbo Li, & Junhong Han. (2023). RNA modification: mechanisms and therapeutic targets. Molecular Biomedicine. 4(1). 25–25. 93 indexed citations
11.
Zhang, Yang, et al.. (2023). Ferroptosis regulation by methylation in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(6). 188972–188972. 19 indexed citations
12.
Zhu, Lina, Yang Du, Yi Ching Esther Wan, et al.. (2021). The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer. Journal of Biological Chemistry. 296. 100374–100374. 18 indexed citations
13.
Zheng, Xuan, Yinghui Jia, Lei Qiu, et al.. (2019). A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator. Journal of Biological Chemistry. 295(6). 1474–1488. 7 indexed citations
14.
Hu, Xiao, Yang Meng, Lian Xu, et al.. (2019). Cul4 E3 ubiquitin ligase regulates ovarian cancer drug resistance by targeting the antiapoptotic protein BIRC3. Cell Death and Disease. 10(2). 104–104. 40 indexed citations
16.
Han, Junhong, Qing Li, Hui Zhou, & Zhiguo Zhang. (2013). Histone modifications regulate DNA replication coupled nucleosome assembly. Epigenetics & Chromatin. 6(S1). 1 indexed citations
17.
Kottom, Theodore J., Junhong Han, Zhiguo Zhang, & Andrew H. Limper. (2010). Pneumocystis carinii Expresses an Active Rtt109 Histone Acetyltransferase. American Journal of Respiratory Cell and Molecular Biology. 44(6). 768–776. 13 indexed citations
18.
Alabert, Constance, Yuki Katou, Su Wu, et al.. (2009). Involvement of a chromatin remodeling complex in damage tolerance during DNA replication. Nature Structural & Molecular Biology. 16(11). 1167–1172. 80 indexed citations
19.
Han, Junhong, Hui Zhou, Bruce Horazdovsky, et al.. (2007). Rtt109 Acetylates Histone H3 Lysine 56 and Functions in DNA Replication. Science. 315(5812). 653–655. 340 indexed citations
20.
Han, Junhong, Hui Zhou, Zhizhong Li, Rui-Ming Xu, & Zhiguo Zhang. (2007). Acetylation of Lysine 56 of Histone H3 Catalyzed by RTT109 and Regulated by ASF1 Is Required for Replisome Integrity. Journal of Biological Chemistry. 282(39). 28587–28596. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026